Retinal thickness and volume
Significant reductions were observed in CST between baseline and the study endpoints in the monotherapy arm. The mean decrease in CST was 76 μm (95% CI 15 to 138, The graph showed mean values of central subfield thickness at baseline and the study endpoints in both study arms. CST: central subfield thickness, IVB: Intravitreal bevacizumab, SCTA: Suprachoroidal triamcinolone acetonideOn the 12th week, a normal CST was observed based on its gender-specific normal threshold values in 8 (25%) and 14 (53.8%) eyes in the monotherapy and combination arms, respectively. The statistical analyses revealed the synergistic effects of a single dose of SCTA, which significantly increased the normal CST values with an odds ratio of 3.5 (95% CI 1.2 to 10.6, In addition to CST, MV significantly decreased in both study arms. After four and twelve weeks, the mean resolution in MV was respectively obtained as 0.7mmThe graph showed mean values of macular volume at baseline and the study endpoints in both study arms. MV: macular volume, IVB: Intravitreal bevacizumab, SCTA: Suprachoroidal triamcinolone acetonide